Hot Flashes Clinical Trials 2023

Hot Flashes Clinical Trials 2023

Hot Flashes research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in hot flashes clinical trials today.

Popular filter options for hot flashes trials

Hot Flashes Clinical Trials With No Placebo

View 13 hot flashes medical studies that do not have a placebo group.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hot flashes

What are the top hospitals conducting hot flashes research?

When it comes to finding relief from the discomfort of hot flashes, several hospitals are leading the way in clinical trials. In Palm Harbor, Florida, Suncoast Clinical Research takes the forefront with three ongoing trials dedicated to addressing hot flashes. Since their first recorded trial in 2011, they have been committed to finding effective solutions for this common symptom experienced by many women. Similarly, Helix Biomedics in Boynton Beach is making strides with two active trials and a recent entry into this area of research in 2021.

Meanwhile, New Port Richey's Suncoast Clinical Research Center joins the ranks with its own two ongoing hot flashes trials and an inaugural investigation also starting in 2021. Eastern Carolina Women's Center in New Bern has not only matched these numbers but also contributed since their first recorded trial back in 2011; showing commitment towards enhancing understanding through a further set of two active studies on hot flashes presently underway.

Lastly entering this space is Advances in Health located at Houston which marks its presence maintaining equivalent statistics as others:two currently running clinical tests accompanied by initiating their investigations recently duringthe year2021- demonstrating continuous growing interest towards resolving issues relatedto managing hot flushes

These hospitals signify hope for those experiencing disruptive hot flashes, providing opportunities for individuals to participate in cutting-edge research aimed at improving quality of life. By prioritizing these clinical trials and actively seeking innovative approaches, these institutions contribute significantly to advancing medical knowledge surrounding this uncomfortable symptom that affects countless people worldwide.

Which are the best cities for hot flashes clinical trials?

Raleigh, North carolina; Columbus, Ohio; Saginaw, Michigan; Memphis, Tennessee; and Mesa, Arizona are among the best cities for hot flashes clinical trials. These cities collectively offer a total of 6 active trials in Raleigh and Columbus, and 4 active trials in Saginaw, Memphis, and Mesa. The studies focus on various experimental treatments such as Elinzanetant (BAY3427080), MF101 5 g/day, EMBr Wave, Oxybutynin Chloride and others. Individuals experiencing hot flashes can potentially find opportunities to participate in cutting-edge research aimed at finding effective solutions to alleviate their symptoms within these cities.

Which are the top treatments for hot flashes being explored in clinical trials?

Hot flash research is actively exploring various treatments to alleviate this common menopausal symptom. One promising option is Elinzanetant (BAY3427080), which is currently being tested in three active trials dedicated to hot flashes. Since its first listing in 2018, it has already made an impact with ten clinical trials focused on this specific area. Another intriguing avenue being explored is a low-fat vegan diet supplemented with 1/2 cup of soybeans daily. While still in the early stages, one ongoing trial investigates the potential benefits of this dietary approach for managing hot flashes. As researchers delve deeper into these options, they bring us closer to finding effective relief for those experiencing disruptive hot flashes during menopause.

What are the most recent clinical trials for hot flashes?

Exciting developments are underway in the realm of hot flash treatment, with recent clinical trials shedding light on potential solutions. One such trial focuses on Elinzanetant (BAY3427080), a Phase 3 study that became available on 10/29/2021 and aims to address hot flashes. Another Phase 3 trial for Elinzanetant (BAY3427080) was conducted, becoming available on 8/27/2021. Additionally, Oxybutynin Chloride underwent a Phase 2 trial specifically targeting hot flashes and became available on 7/30/2021. These studies offer hope for those experiencing this often uncomfortable symptom by exploring novel treatments that may alleviate the impact of hot flashes.

What hot flashes clinical trials were recently completed?

Recently concluded clinical trials have made significant strides in improving the treatment of hot flashes, a common and often disruptive symptom. In July 2019, Astellas Pharma Global Development successfully completed a trial examining the efficacy of fezolinetant in alleviating hot flashes. Similarly, in April 2017, Dr. Alison Huang led a study investigating the use of transdermal nitroglycerin for managing this bothersome condition. These advancements offer hope for individuals experiencing hot flashes and highlight ongoing efforts to provide effective relief from this menopausal symptom.